Feline C-Peptide antibody and antigen (recombinant protein)
Diagnostic anti-Feline C-Peptide antibodies pairs and antigen for animal health (animal Cat/Feline type 1 diabetes mellitus) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to type 1 diabetes mellitus diagnostics products collection
>>
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-FEL-C-Peptide-Ag01 | Recombinant Feline C-Peptide protein | 3090 | ||
GMP-FEL-C-Peptide-Ab01 | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-FEL-C-Peptide-Ab02 | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-FEL-C-Peptide-Ab03 | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-FEL-C-Peptide-Ab04 | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-FEL-C-Peptide-Ag01 |
Product Name | Recombinant Feline C-Peptide protein |
Target/Biomarker | Feline C-peptide |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Cat/Feline with type 1 diabetes mellitus. |
Tag | His |
Products description | Recombinant Feline C-Peptide protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-C-Peptide-Ab01, GMP-FEL-C-Peptide-Ab02, GMP-FEL-C-Peptide-Ab03, GMP-FEL-C-Peptide-Ab04 |
Product Name | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline C-peptide |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Anti-Feline C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Cat/Feline with type 1 diabetes mellitus. |
Tag | mFc |
Products description | Anti-Feline C-Peptide mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Feline C-Peptide, a remarkable peptide composed of 31 amino acids, is intricately intertwined with the physiological tapestry of cats. It emerges as a critical component of pancreatic function, serving as both a mirror and a marker of endogenous insulin production. C-Peptide is born during the proteolytic cleavage of proinsulin, a precursor to insulin. While insulin takes on the central role in regulating glucose homeostasis, Feline C-Peptide plays a parallel and equally crucial role, co-secreted alongside insulin by the pancreas. Feline C-Peptide follows a pulsatile release pattern into the bloodstream, a pattern that mimics the body's natural insulin secretion. This distinctive feature sets it apart from exogenously administered insulin, which delivers a continuous and uniform dose. As C-Peptide levels rise in response to elevated blood glucose levels, it serves as an invaluable indicator of the pancreas's health and its ability to produce insulin. Beyond its role as a mirror of insulin secretion, Feline C-Peptide plays an essential role in the diagnosis and differentiation of diabetes in cats. This differentiation is not merely a matter of semantics but a pivotal determinant of treatment approaches. Low or undetectable levels of C-Peptide are typically associated with Type 1 diabetes, which results from the autoimmune destruction of pancreatic beta cells, leading to the absence of endogenous insulin production. In contrast, Type 2 diabetes in cats is characterized by varying C-Peptide levels, reflecting a complex interplay of insulin resistance and impaired insulin secretion. The ability to distinguish between these two forms of diabetes guides veterinarians in selecting the most appropriate therapeutic strategies for their feline patients.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.